share_log

《大行報告》瑞信上調華潤醫療(01515.HK)目標價至6.8元 評級「中性」

AASTOCKS ·  Mar 1, 2023 02:35

瑞信發表報告指,華潤醫療(01515.HK)早前完成由母公司收購遼寧華潤健康和江能標的股權。基於管理層舉行的業務更新電話會議,該行估計兩項交易約以去年市盈率14倍完成,相信對公司有利。

另外,管理層提到,今年1月的總患者就診量和手術量都超過去年同期水平,但收入組合要恢復正常水平仍然需時。

瑞信下調華潤醫療去年純利預測64%,反映公司最新公布的盈利警告,今明兩年則因完成收購而分別調升25%及55%,同時將其股份目標價由6元上調至6.8元,評級維持「中性」。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 220

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.